Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Recreation Days Held during Second National Polio Immunization Campaigns (2014)

 
Second National Immunization Campaign against Polio
 
During 15th -21st November 2014, the Second National Polio Immunization Campaign was implemented in collaboration with UNICEF and WHO,  through which a series of Polio Vaccination Recreation Days were planned covering different areas in Lebanon, including: Tripoli, Deir Ammar, Meniyeh Danniyeh, Bebnine, Baalbeck, Beirut, Saida and Iqlim El-Kharoub.
 
These Recreation Days achieved a greater success by reaching 96% of the Primary Health Care department's target in vaccinating children under 5 years old against polio, among which 45% of the total vaccinated children were Syrian and other nationalities.
Examples of the Recreation days held in November are:
 
Recreation Day at Riyadi Club, Beirut
On Monday, November 17th 2014 a successful Recreation Day was held for school children at Riyadi Club, Beirut. This event was organized by the Primary Health Care Department (MoPH) in collaboration with UNICEF, and attended by representatives from WHO and IMC.
During this day approximately 200 students, under the age of 5 years old, from the schools of Dar el Aytam el Islamiya and Al Makassed, were vaccinated under the supervision of Registered Nurses from Primary Health Care Centers of Dar el Fatwa, Makhzoumi Foundation, Al Makassed Charitable Society and Beirut Development Association Center.
In addition to the free polio vaccination, the participating children were entertained with clowns and lively plays performed by ‘’The Arab Puppet Theatre Foundation’’. At the end of the event, The Rotary Club distributed snacks and coloring books to the children.
 

Karakozian Primary Health Care Center
On Tuesday 18th November 2014, UNICEF conducted a documentary shooting session at Karakozian Primary Health Care Center concerning the Second National Immunization Campaign against Polio. The essential role the Ministry plays in preventing poliomyelitis disease through organizing such National Polio Vaccination Campaigns was reported. Furthermore, the proceeding of the campaign was presented and parents’ opinion regarding the campaign and the reason behind vaccinating their children was also highlighted.
 

Recreation Day at Ch’him
On Thursday, 20th November 2014 another successful Recreation Day was also held at Ch’him Educational Hall, which happened to take place simultaneously with the celebration of Lebanon’s Independence Day reflected in the attending children’s costumes and celebration spirit.
During this event, 958 children under the age of 5 years old were vaccinated against polio, attending from schools located in the region of ‘’Iqlim Kharoub’’. Out of a total of 42 private and public schools in this region, 17 schools participated, and out of 15 public schools, 8 schools attended this event.
Aside from the free polio vaccination, the children were also entertained with several activities, including: puppet shows, musical plays and songs. The children were also given coloring books and snacks at the end of the event by the Rotary Club.
 
    ...
    6
ATC Name B/G Ingredients Dosage Form Price
L01FA01 RUXIENCE BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 13,157,756 L.L
L01FA01 RITUXIREL BioTech Rituximab - 500mg 500mg/50ml Injectable concentrated solution 45,258,360 L.L
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 64,401,569 L.L
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 111,983,163 L.L
L01FA01 RUXIENCE BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 59,148,151 L.L
A10AD06 RYZODEG BioTech Insulin degludec - 70%, Insulin aspart - 30% 100IU/ml Injectable solution 7,058,661 L.L
L04AB02 REMICADE BioTech Infliximab - 100mg 100mg Injectable concentrated powder for solution 30,111,023 L.L
L04AB02 REMSIMA BioTech Infliximab - 100mg 100mg Injectable concentrated powder for solution 24,943,134 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
C10AX13 REPATHA BioTech Evolocumab - 140mg/1ml Injectable solution 44,151,793 L.L
B03XA06 REBLOZYL BioTech Luspatarcept - 25mg 25mg Injectable powder for solution 125,960,784 L.L
B03XA06 REBLOZYL BioTech Luspatercept - 75mg 75mg Injectable powder for solution 377,881,318 L.L
L01FX18 RYBREVANT BioTech Amivantamab - 350mg 350mg Injectable concentrate for solution 135,818,621 L.L
J06BB01 RHOPHYLAC 300 BioHuman Human anti-D (rh) immunoglobulin - 300mcg/2ml 300mcg/2ml Injectable solution 5,939,784 L.L
J06BB01 RHESONATIV BioHuman Human anti-D (rh) immunoglobulin - 625IU/ml 625IU/ml Injectable solution 12,281,758 L.L
J06BB05 RABISHIELD-100 (RABIES HUMAN MONOCLONAL ANTIBODY rDNA) BioHuman Rabies, Human IgG1 Monoclonal Antibody - 100IU/2.5ml 100IU/2.5ml 8,455,824 L.L
C01EB18 RANEXA B Ranolazine - 375mg 375mg Tablet, prolonged release 3,985,837 L.L
C01EB18 RANEXA B Ranolazine - 500mg 500mg Tablet, prolonged release 3,985,837 L.L
C01EB18 RANEXA B Ranolazine - 750mg 750mg Tablet, prolonged release 3,985,837 L.L
A02AC10 RENNIE B Magnesium carbonate - 80mg, Calcium carbonate - 680mg Tablet, chewable 240,548 L.L
A06AX05 RESOLOR B Prucalopride succinate - 2mg 2mg Tablet, film coated 5,251,736 L.L
A06AX05 RESOLOR B Prucalopride succinate - 1mg 1mg Tablet, film coated 3,273,600 L.L
R01AB08 RINOFLUIMUCIL B Acetylcysteine - 1%, Tuaminoheptane sulfate - 0.5%, Benzalkonium chloride - 0.0125% Solution 419,279 L.L
L04AA10 RAPAMUNE B Sirolimus - 1mg 1mg Tablet 12,907,489 L.L
L04AA10 RAPAMUNE B Sirolimus - 1mg 1mg Tablet L.L
    ...
    6
Sitemap
© Copyrights reserved to Ministry of Public Health 2025